Posts by Follicle Thought
PTD-DBM Update: Q&A With Dr. Kang-Yell Choi
2021 Q&A With Dr. Kang-Yell Choi: Update (9/14/21) I was recently able to conduct another Q&A with Dr. Kang-Yell Choi who gives the latest updates on his company below. Among the updates, Dr. Choi’s startup aimed at commercializing drugs which target the CXXC5 protein is now going by a new name, CK Regeon. FT: What’s…
Read MoreStemson Therapeutics Featured In Atlantic Article
The hair multiplication company from La Jolla, California has been making headlines all across the internet since its presentation at the ISSCR meeting and the launch of its website in late June 2019. After the initial publication and announcement was released on the Sanford Burnham Prebys website (affiliated organization with Stemson Tx) many articles were…
Read MorePoietis & L’Oreal: Bioprinted Hair Follicle Update
In 2016, L’Oreal announced a new research collaboration with the company Poietis who specializes in bioprinting. The purpose of the joint venture was to accomplish the ambitious task of creating a bioprinted hair follicle. In this article I have an update from Poietis on the progress of their hair follicle project. First, let’s take a…
Read MoreA Histogen Review In 2019: Part 2 (Mexico Update)
This article is a continuation of a previous deep dive into one of the most fascinating stories in the biotech industry. The Ziering Study We left off in the previous article with the release of data from Dr. Craig Ziering’s independent trial of HSC. This small study has literally produced the most data we’ve ever…
Read MoreA Histogen Review In 2019
The biotech startup from San Diego has had quite a background story since emerging onto the hair scene back in 2009. It had occurred to me that Histogen is now officially the longest-running “in development” hair-growth company in the world. And, when you look at that beginning date closely it starts to make sense –…
Read MorePermanent Chemotherapy-Induced Alopecia Reversal
A topic that is rarely covered among hair loss publications is the phenomenon of chemotherapy-induced alopecia and specifically, permanent chemotherapy-induced alopecia. Chemotherapy and Hair Loss Around 2 million people may develop breast cancer each year globally, according to the World Cancer Research Fund. For these people who receive a breast cancer diagnosis, one the most…
Read MoreStemson Therapeutics New Website
Stemson Therapeutics, a biotech company working on a cure to create unlimited hair growth, issued an important press release about its research and the launching of its website on June 26, 2019. The company is based in La Jolla, California and was founded by Sanford Burnham Prebys researcher Dr. Alexey Terskikh and Geoff Hamilton in…
Read MoreColumbia University 3D Printing Hair
Dr. Angela Christiano and her team from Columbia University are back in the headlines for a range of new hair growth discoveries, one of them being progress on the 3D printing of hair follicles. 3D Follicles In The Dish It’s no secret that Angela Christiano has been studying the biology of hair follicles for decades.…
Read MoreAclaris Positive 6 Month Results In AGA With Photos
On June 17, 2019, Aclaris Therapeutics Inc. issued a press release announcing positive results from a phase 2 clinical trial for men and women with androgenic alopecia. Trial Details From the press release: the trial results included 22 subjects of both men and women who applied a 0.46% solution of ATI-502 to their scalps twice…
Read MoreFollica Announces Positive Data 2019
Boston based hair growth company Follica has announced positive data from its ongoing safety and optimization study and is prepared to move into a pivotal FDA study later this year. Upon checking my email this morning I found a message from a top level executive at Follica pointing me to a press release sent out…
Read More